The stock of Theralase Technologies Inc. (CVE:TLT) is a huge mover today! The stock last traded at $0.41 per share. It is down 6.00% since August 14, 2016 and is uptrending. It has underperformed by 10.49% the S&P500.
The move comes after 9 months positive chart setup for the $43.36M company. It was reported on Sep, 13 by Barchart.com. We have $0.86 PT which if reached, will make CVE:TLT worth $47.26 million more.
Theralase Technologies Inc. is a biotech firm focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds to destroy cancer. The company has a market cap of $43.36 million. The Firm operates through two divisions: Therapeutic Laser Technology (TLT) division and Photo Dynamic Therapy (PDT) division. It currently has negative earnings. The TLT division designs, develops, makes and markets super-pulsed laser technology indicated for the healing of chronic knee pain.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.